Prof. Claire Foster
This includes large prospective UK wide cohort studies including collection of clinical and patient reported questionnaires to understand the consequences of cancer from diagnosis and over time, how this can impact on people’s daily lives, and identifying areas for intervention [e.g. CREW 1,000 and HORIZONS 3,000 cohorts]. Claire’s research team has developed and tested web-based resources to support self-management of fatigue following cancer treatment [RESTORE www.macmillanrestore.org.uk] and decision aids to support younger women with breast cancer facing decisions about surgery and genetic testing [Breast Cancer Choices].
Projects are underway to develop web-based resources to support people making complex decisions when living with Motor Neurone Disease (DiAMoND, PI Wheelwright) and increased risk of cancer due to genetic susceptibility (CRUK Catalyst Award, CI Turnbull).
The research team is leading the evaluation of NHS England and Health Education England practice-based transformation projects to improve access to nursing and self-management support from the point of cancer diagnosis and following treatment. Research funding has been awarded from a range of sources including Macmillan Cancer Support, Movember Foundation, National Institute for Health Research, Breast Cancer Now, Prostate Cancer UK, Cancer Research UK, Health Foundation, Roy Castle Lung Cancer Foundation, Marie Curie and MND Association, Dimbleby Cancer Care, Research UK.
Claire is a member of Bowel Cancer UK’s Scientific Advisory Board, National Cancer Research Institute Methodology Workstream and a member of British Psychosocial Oncology Society Executive.
Title: Why do patient reported outcomes matter in cancer care?
Summary: This talk will introduce psychosocial aspects of cancer and survivorship and consider why patient reported outcomes and experiences are essential for improving cancer care. Carefully collecting information from representative groups of patients from the point of diagnosis, during treatment and in the years beyond can identify who is most likely to need support and when, how we identify people most at risk of experiencing difficulties and how we can support them to live with and manage the impact of their cancer and its treatment in their daily lives. Examples from the Macmillan Survivorship Research Group will be drawn on to illustrate why patient reported outcomes matter and how data can be used to improve care.
Donate to Cancer Research
All donations to the IACR go directly towards supporting early-stage oncology scientific researchers in their work.
IACR 2023 Carer’s Bursary €300
Apply for funding towards the additional costs of care while attending conference. Five Bursaries Available.
Registration/ Membership for IACR 2023
Registration for the 59th Annual Conference in the Radisson Blu hotel, Athlone is Now Open.
EACR Membership is Included
The IACR is an affiliated national society and its members benefit from full membership of the EACR.
Late Breaking Abstracts in Now OPEN!
Biomedical Session Abstracts
Deadline: Midnight, Friday, 20th January 2023
- Patrick Johnston Lay submission category is now closed
- Late Breaking Abstracts submitted to the Biomedical Sessions will be considered for Display Poster Presentation.
Social Nursing and Allied Health (SNAH) Abstracts
Deadline: Midnight, Monday, 9th January 2023
SNAH abstract submissions will remain open until Monday 9th January.
Please contact Sinead on: email@example.com
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.
Registered Charity Number (RCN): 20030117